1.Murine double minute 2 309 T >G polymorphism is associated with gastrointestinal cancer risk especially in Asians: a meta-analysis
Wenye MA ; Ying DONG ; Zhiqiang CHEN ; Guanhua WANG ; Chaoyong TIAN ; Yanrong WANG ; Wenjun YANG
Cancer Research and Clinic 2015;27(1):47-51
Objective To comprehensively evaluate the relationship between murine double minute 2 (MDM2) gene promoter SNP309 T>G polymorphism and the susceptibility of gastrointestinal cancer.Methods The China National Knowledge Infrastructure (CNKI),WanFang database,SpringerLink database and PubMed were retrieved to get all case-control research literatures (2005-2012) on the relationship of MDM2 gene SNP309 T>G and gastrointestinal cancer susceptibility.Meta-analysis with RevMan 4.2 was used to combine OR values of the relationship between SNP309 T>G and gastrointestinal cancer susceptibility.A sensitivity analysis and tested publication bias were made with all selected literatures' data.Results A total of 17 domestic and foreign qualified papers were included in this study.Twenty case-control studies including 5 183 cases and 6 660 controls were identified for the present meta-analysis.A significant association was detected between the MDM2 SNP309 T>G polymorphism and gastrointestinal cancer risk.The meta-aualysis showed that the combined odds ratio (OR) for GG genotype was 2.23 (95 % CI =1.73-2.89,P < 0.01) compared with that for TG + TT genotypes.There was no statistical significance for the evaluation of publication bias.Conclusion The GG genotype of MDM2 SNP309 may increase gastrointestinal cancer risk in Asians.
2.Effect of Synergistic Treatment with Qingjin Huazhuo Formula (清金化浊方) on Thrombotic Events in Hospitalized Patients of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Phlegm Heat Stasis Obstructing in the Lung Syndrome: A Retrospective Cohort Study
Jizhang MA ; Lina HUANG ; Wenye FENG ; Feng GAO
Journal of Traditional Chinese Medicine 2023;64(18):1897-1902
ObjectiveTo analyze the effect and possible mechanism of the synergistic treatment with Qingjin Huazhuo Formula (清金化浊方, QHF) on the occurrence of thrombotic events in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and phlegm heat stasis obstructing in the lung syndrome. MethodsIn a retrospective cohort study, 305 AECOPD inpatients with the syndrome of phlegm heat stasis obstructing in the lung were included. According to whether using QHF (the course of treatment ≥ 7 days), they were divided into the exposure group (193 cases) and the non-exposure group (112 cases). Totally, 109 pairs of cases were obtained by 1∶1 propensity score matching (PSM). After matching, the occurrence of thrombotic events during hospitalization, the remission of main symptoms or signs (including cough, expectoration, wheezing, cyanosis) after 10 days (±3 days) of treatment, and the difference of the indicators including D-dimer, percentage of neutrophils (NEUT%), C-reactive protein (CRP), arterial partial pressure of oxygen (PaO2), and arterial partial pressure of carbon dioxide (PaCO2) before treatment and after 10 days (±3 days) of treatment during the first auxiliary examination. ResultsAfter matching, the incidence of thrombotic events during hospitalization in the exposure group (5 cases, 4.59%) were lower than that of the non-exposure group (15 cases, 13.76%, P<0.05). The exposure factor that taking QHF for 7 days or above was a protective factor for thrombotic events in AECOPD hospitalized patients with phlegm heat stasis obstructing in the lung syndrome (RR = 0.333, 95% CI 0.126 to 0.885). The remission rates of cough (100/109, 91.74%), expectoration (103/109, 94.50%), wheezing (102/109, 93.58%), and cyanosis (97/109, 88.99%) in the exposure group were significantly higher than those in the non-exposure group (90/109, 82.57%; 94/109, 86.24%; 89/109, 81.65%; 86/109, 78.90%) after treatment (P<0.05). After treatment, the levels of D-dimer, NEUT%, CRP and PaCO2 in both groups significantly decreased (all P<0.05), and the level of PaO2 significantly increased (P<0.05). The difference of the levels of D-dimer, NEUT% and PaO2 in the exposure group before and after treatment were larger than those in the non-exposure group (P<0.05), while the pre-post difference of CRP and PaCO2 were not significantly different between the two groups (P>0.05). ConclusionThe synergistic treatment with QHF can effectively reduce the occurrence of thrombotic events, alleviate the clinical symptoms or signs such as cough, expectoration, wheezing, and cyanosis, and can improve lung function in hospita-lized patients with AECOPD and phlegm heat stasis obstructing in the lung syndrome. Its mechanism may be related to improving blood coagulation and inflammatory status.
3.The influence of two kinds of transnasal endoscopic surgery on the outcome status of sinus cavity in patients with eosinophilic chronic rhinosinusitis with nasal polyps
Yongjin WU ; Tao LIU ; Jianren MA ; Wenye WANG ; Shumin OU ; Yong ZHAO ; Jie GAO ; Geng XU ; Yueqi SUN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2022;57(12):1450-1456
Objective:To investigate the trend of postoperative cavity status in patients with eosinophilic chronic sinusitis with nasal polyps (eCRSwNP) who underwent total nasalization surgery and partial reboot surgery. And to discuss the relationship between tissue eosinophil counts and status of postoperative cavity.Methods:Patients with eCRSwNP in four tertiary medical centers (Longgang ENT Hospital, Xiamen Humanity Hospital, Guangdong Clifford Hospital and the First Affiliated Hospital of Sun Yat-Sen University) from March 2018 to October 2021 were divided into 2 groups. The group without previous surgery history was performed for the nasalization surgery, and another group with previous surgery history underwent the part-reboot surgery. The follow-up time after operation was defined as the following 5 stages: 6, 12, 20-24, 36 and more than 42 months. According to FESS-95 Guangzhou standard, status of sinus cavity was assessed and classified into 3 categories: good, better and bad. The association between the sinus cavity status and tissue eosinophil counts in the above 5 stages was analyzed by one-way ANOVA, and P<0.05 was considered statistically significant. Results:A total of 72 eCRSwNP patients finished the follow-up in this study. There were 47 males and 25 females in these patients, aged from 11 to 67 years. A total of 50 cases underwent nasalization surgery and 22 cases underwent partial reboot surgery. With the follow-up time from 6 to 48 months, there were 72 cases (100.0%) who completed 6 months and 12 months follow up, 46 cases (63.9%) for 20-24 months, 36 cases (50.0%) for 32-36 months and 16 cases (22.2%) with the follow-up time more than 42 months. No matter what kind of surgery, there was no "bad" situation of the surgical cavity status 6 months after the operation, and the differentiation gradually occurred more than 12 months after the surgery. Moreover, the rates of "good" cavity status for the 5 stages in the group of nasalization surgery were 78.0%, 66.0%, 56.7%, 47.6% and 42.9%, and were 63.6%, 45.5%, 25.0%, 20.0% and 11.1% in the partial reboot surgery group, respectively, suggesting that the status of nasal cavity in nasalization surgery group was always better than that in partial reboot surgery group in every period. In addition, the "bad" rate was 0, 8.0%, 10.0%, 14.3% and 28.6% in the group of nasalization surgery, and was 0, 27.3%, 18.8%, 33.3% and 55.6% in the partial reboot surgery group, respectively. The average percentage of tissue eosinophil counts in the 72 cases was 42.1%, which had no obvious effect on the status of the surgical cavity ( P>0.05). Conclusions:For eCRSwNP patients, the operative cavity status in the patients without previous operation history treated with nasalization surgery is good. The time of 1-2 years after surgery is the main period for sinus lesions. The counts of tissue eosinophils has no significant influence on surgical sinus cavity status in the eCRSwNP patients.